MIND and Mediterranean Diets Tied to Delayed Parkinson Onset
THURSDAY, Jan. 28, 2021 -- There is a strong correlation between the age of onset of Parkinson disease (PD) and dietary habits, according to a study published online Jan. 6 in Movement Disorders.
Avril Metcalfe-Roach, from the University of British Columbia in Vancouver, Canada, and colleagues analyzed data from food frequency questionnaires completed by 167 individuals with PD and 119 controls.
The researchers found that overall, women adhered more closely to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet than men, and diet scores were not modified by disease status. MIND diet adherence correlated with later age of onset most strongly in women, corresponding to differences of up to 17.4 years between low and high dietary tertiles. There was also a significant association seen between Greek Mediterranean adherence and later PD onset across all models. In men, only Greek Mediterranean diet adherence correlated with later onset, with differences of up to 8.4 years.
"Nutritional strategies may be an effective tool to delay PD onset," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Read this next
THURSDAY, March 4, 2021 -- Intakes of eggs and cholesterol are associated with higher all-cause, cardiovascular disease (CVD), and cancer mortality, according to a study published...
TUESDAY, March 2, 2021 -- Higher intakes of dietary fiber, dietary calcium, and yogurt and lower intakes of red meat and alcohol are associated with a lower risk for colorectal...
MONDAY, March 1, 2021 -- Mortality is lowest with consumption of five servings of fruit and vegetables per day, according to a study published online March 1 in Circulation. Dong...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.